Please find the attached Newspaper Notice for Publication of Q4 and Year ended 31 March, 2026 Results
Awaiting price reaction for this filing.
Cresanto Global Ltd (formerly Raymed Labs Limited, Scrip Code: 531207) published newspaper notices of its standalone audited financial results for Q4 and the financial year ended 31 March 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors on 28 May 2026. The company disclosed that full audited financial results have been filed with stock exchanges under SEBI Regulation 33 and are available on BSE's website and the company's website (www.raymedlab.com). The same were published in Business Standard (English and Hindi) on 29 May 2026.
The filing is a regulatory disclosure confirming Q4 and FY2026 results publication. Specific financial numbers are not included in the newspaper notice — investors should refer to the full financial results filing on BSE/NSE for detailed figures.